Effect of a drug called dexmeditomiodine on two similar kind of local anesthetic- ropivacaine and levobupivacaine in a nerve block for post operative pain relief in Fracture neck of femur

The effect of dexmedetomidine on 0.25% levobupivacaine and 0.25% ropivacaine in fascia iliaca block. A randomized trial - DEXLAR

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/12/016670

Enrollment

Registered

2018-12-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmetedomidine with 0.25% ropivacaine: Dexmetedomidine with 0.25% ropivacaine to be administered in post operative cases of Fracture neck of femur for fascia iliaca block Control Inter

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 to 60 years of age of either gender American society of anesthesiologists (ASA) physical status Class I and II Sensory and motor function in affected limb will be selected Surgery under Spinal anesthesia.

Exclusion criteria

Exclusion criteria: previous femoral bypass surgery patients with inguinal hernia patients on previous opioid therapy, psychiatric disorders and polytrauma. obese and short neck patients coagulopathy neuropathy local infection at the site for block history of allergy to the study drugs surgery under Genreal anesthesia.

Design outcomes

Primary

Measure	Time frame
Time duration to VAS Scoring of Post operative pain more than 3Timepoint: Time when block is given to the time when first dose of tramadol is given in first 24 hours	—

Secondary

Measure	Time frame
Total requirement of rescue analgesia in 24 hoursTimepoint: 24 hours	—

Countries

India

Contacts

Public ContactDr Bhavna Sriramka

IMS and SUM Hospital, Siksha O Anusandhan Deemed to be University

bhavna.sriramka@gmail.com7751007807

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026